Xtant Medical Holdings Stock Price To Sales

XTNT Stock

USD 0.40 0.01 2.44%

Xtant Medical Holdings fundamentals help investors to digest information that contributes to Xtant Medical's financial success or failures. It also enables traders to predict the movement of Xtant Stock. The fundamental analysis module provides a way to measure Xtant Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Xtant Medical stock.

		Last Reported	Projected for Next Year
	Price To Sales Ratio	1.47	1.40

Price To Sales Ratio is likely to drop to 1.40 in 2024.

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Xtant Medical Holdings Company Price To Sales Analysis

Xtant Medical's Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.

P/S

MV Per Share

Revenue Per Share

More About Price To Sales | All Equity Analysis

Current Xtant Medical Price To Sales

0.50 X

Most of Xtant Medical's fundamental indicators, such as Price To Sales, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Xtant Medical Holdings is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Xtant Price To Sales Driver Correlations

Understanding the fundamental principles of building solid financial models for Xtant Medical is extremely important. It helps to project a fair market value of Xtant Stock properly, considering its historical fundamentals such as Price To Sales. Since Xtant Medical's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Xtant Medical's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Xtant Medical's interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Total Liab	Total Current Assets	Current Deferred Revenue	Short Term Debt	Intangible Assets	Common Stock	Long Term Debt	Property Plant Equipment	Good Will	Net Tangible Assets	Short Long Term Debt	Long Term Debt Total	Capital Surpluse	Net Invested Capital	Net Working Capital
Total Assets		0.0	0.76	-0.16	0.92	0.76	0.82	0.76	0.83	0.15	0.91	-0.42	0.75	0.92	0.9	-0.52	0.61	0.08	0.02	0.2	0.11
Total Stockholder Equity	0.0		-0.62	-0.24	-0.17	0.31	-0.52	0.29	-0.22	0.39	-0.01	-0.03	-0.64	-0.17	-0.26	0.81	-0.43	-0.69	0.52	0.03	0.5
Net Debt	0.76	-0.62		0.04	0.81	0.44	0.98	0.34	0.77	-0.11	0.73	-0.25	0.99	0.84	0.88	-0.92	0.74	0.5	-0.36	0.12	-0.28
Retained Earnings	-0.16	-0.24	0.04		-0.05	-0.46	-0.05	-0.65	-0.35	-0.39	0.18	0.52	0.02	-0.04	0.11	-0.33	0.04	0.83	-0.88	0.79	-0.66
Accounts Payable	0.92	-0.17	0.81	-0.05		0.72	0.87	0.64	0.77	-0.03	0.82	-0.44	0.8	0.88	0.87	-0.62	0.62	0.26	-0.15	0.3	0.02
Net Receivables	0.76	0.31	0.44	-0.46	0.72		0.56	0.77	0.61	0.18	0.6	-0.5	0.41	0.68	0.55	-0.09	0.25	-0.3	0.29	-0.01	0.45
Total Liab	0.82	-0.52	0.98	-0.05	0.87	0.56		0.44	0.83	-0.12	0.76	-0.36	0.98	0.88	0.9	-0.86	0.75	0.41	-0.3	0.11	-0.17
Total Current Assets	0.76	0.29	0.34	-0.65	0.64	0.77	0.44		0.67	0.29	0.46	-0.63	0.36	0.57	0.44	-0.02	0.26	-0.46	0.62	-0.19	0.62
Current Deferred Revenue	0.83	-0.22	0.77	-0.35	0.77	0.61	0.83	0.67		0.11	0.62	-0.46	0.78	0.72	0.84	-0.58	0.82	0.03	0.1	-0.01	0.07
Short Term Debt	0.15	0.39	-0.11	-0.39	-0.03	0.18	-0.12	0.29	0.11		0.08	-0.06	-0.16	0.09	0.03	0.27	-0.23	-0.53	0.49	-0.35	-0.03
Intangible Assets	0.91	-0.01	0.73	0.18	0.82	0.6	0.76	0.46	0.62	0.08		-0.16	0.71	0.89	0.9	-0.58	0.56	0.3	-0.28	0.39	-0.15
Common Stock	-0.42	-0.03	-0.25	0.52	-0.44	-0.5	-0.36	-0.63	-0.46	-0.06	-0.16		-0.27	-0.32	-0.19	0.05	-0.17	0.26	-0.29	0.28	-0.22
Long Term Debt	0.75	-0.64	0.99	0.02	0.8	0.41	0.98	0.36	0.78	-0.16	0.71	-0.27		0.83	0.87	-0.92	0.76	0.49	-0.34	0.1	-0.23
Property Plant Equipment	0.92	-0.17	0.84	-0.04	0.88	0.68	0.88	0.57	0.72	0.09	0.89	-0.32	0.83		0.9	-0.65	0.5	0.24	-0.18	0.18	-0.03
Good Will	0.9	-0.26	0.88	0.11	0.87	0.55	0.9	0.44	0.84	0.03	0.9	-0.19	0.87	0.9		-0.76	0.78	0.38	-0.31	0.35	-0.21
Net Tangible Assets	-0.52	0.81	-0.92	-0.33	-0.62	-0.09	-0.86	-0.02	-0.58	0.27	-0.58	0.05	-0.92	-0.65	-0.76		-0.72	-0.76	0.61	-0.25	0.51
Short Long Term Debt	0.61	-0.43	0.74	0.04	0.62	0.25	0.75	0.26	0.82	-0.23	0.56	-0.17	0.76	0.5	0.78	-0.72		0.37	-0.26	0.2	-0.24
Long Term Debt Total	0.08	-0.69	0.5	0.83	0.26	-0.3	0.41	-0.46	0.03	-0.53	0.3	0.26	0.49	0.24	0.38	-0.76	0.37		-0.93	0.65	-0.67
Capital Surpluse	0.02	0.52	-0.36	-0.88	-0.15	0.29	-0.3	0.62	0.1	0.49	-0.28	-0.29	-0.34	-0.18	-0.31	0.61	-0.26	-0.93		-0.64	0.77
Net Invested Capital	0.2	0.03	0.12	0.79	0.3	-0.01	0.11	-0.19	-0.01	-0.35	0.39	0.28	0.1	0.18	0.35	-0.25	0.2	0.65	-0.64		-0.28
Net Working Capital	0.11	0.5	-0.28	-0.66	0.02	0.45	-0.17	0.62	0.07	-0.03	-0.15	-0.22	-0.23	-0.03	-0.21	0.51	-0.24	-0.67	0.77	-0.28

Click cells to compare fundamentals

Xtant Price To Sales Historical Pattern

Today, most investors in Xtant Medical Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Xtant Medical's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's price to sales growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Xtant Medical price to sales as a starting point in their analysis.

Xtant Medical Price To Sales

Timeline

The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.

Competition

Predict Xtant Medical

Price To Sales Ratio Over Time

Xtant Price To Sales Ratio

Price To Sales Ratio

1.4

At this time, Xtant Medical's Price To Sales Ratio is comparatively stable compared to the past year.

Based on the latest financial disclosure, Xtant Medical Holdings has a Price To Sales of 0.5012 times. This is 97.66% lower than that of the Health Care Equipment & Supplies sector and 89.51% lower than that of the Health Care industry. The price to sales for all United States stocks is 95.61% higher than that of the company.

Xtant Price To Sales Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Xtant Medical's direct or indirect competition against its Price To Sales to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Xtant Medical could also be used in its relative valuation, which is a method of valuing Xtant Medical by comparing valuation metrics of similar companies.

Xtant Medical is currently under evaluation in price to sales category among its peers.

Xtant Medical Current Valuation Drivers

We derive many important indicators used in calculating different scores of Xtant Medical from analyzing Xtant Medical's financial statements. These drivers represent accounts that assess Xtant Medical's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Xtant Medical's important valuation drivers and their relationship over time.

	2019	2020	2021	2022	2023	2024 (projected)
Market Cap	21.1M	34.1M	47.9M	62.1M	134.6M	141.3M
Enterprise Value	94.4M	50.3M	46.5M	58.9M	152.4M	107.5M

Xtant Fundamentals

	Return On Equity	-0.0877
	Return On Asset	-0.11
	Profit Margin	(0.03) %
	Operating Margin	(0.1) %
	Current Valuation	84.96 M
	Shares Outstanding	139.01 M
	Shares Owned By Insiders	7.83 %
	Shares Owned By Institutions	65.12 %
	Number Of Shares Shorted	197.47 K
	Price To Earning	(0.41) X
	Price To Book	1.22 X
	Price To Sales	0.50 X
	Revenue	91.3 M
	Gross Profit	32.14 M
	EBITDA	5.07 M
	Net Income	660 K
	Cash And Equivalents	16.5 M
	Cash Per Share	0.19 X
	Total Debt	23.56 M
	Debt To Equity	0.60 %
	Current Ratio	3.57 X
	Book Value Per Share	0.39 X
	Cash Flow From Operations	(9.52 M)
	Short Ratio	6.92 X
	Earnings Per Share	(0.13) X
	Price To Earnings To Growth	(0.03) X
	Target Price	2.25
	Number Of Employees	207
	Beta	0.39
	Market Capitalization	55.6 M
	Total Asset	92.61 M
	Retained Earnings	(243.01 M)
	Working Capital	41.88 M
	Current Asset	45.04 M
	Current Liabilities	21.47 M
	Net Asset	92.61 M

About Xtant Medical Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Xtant Medical Holdings's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Xtant Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Xtant Medical Holdings based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Xtant Stock Analysis

When running Xtant Medical's price analysis, check to measure Xtant Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Xtant Medical is operating at the current time. Most of Xtant Medical's value examination focuses on studying past and present price action to predict the probability of Xtant Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Xtant Medical's price. Additionally, you may evaluate how the addition of Xtant Medical to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC